FDA Import Refusal SCS-0007910-8/31/1 — Cadila Pharmaceuticals Limited
The FDA refused shipment SCS-0007910-8/31/1 from Cadila Pharmaceuticals Limited (India) on May 20, 2025. The refused product falls under Drugs and Biologics — ALBENDAZOLE (ANTIPARASITIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 20, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60ZCA02 ALBENDAZOLE (ANTIPARASITIC)
- Charges
- 75